Editor's Choice for June 2018
Published: 4 Jul 2018
Views: 3092
Prof Gordon McVie - Founding Editor, ecancer
- Categories:
- Brain & nervous system
- Breast
- Colorectal & gastro
- Haematology oncology
- Head & neck
- Hepatobiliary pancreatic
- Lung & pleura
- Melanoma & skin
- Neuroendocrine
- Ovary & gynaecology
- Paediatric
- Prostate & urology
- Sarcomas
- Complementary medicine
- Elderly
- Nursing
- Nutrition & wellbeing
- Palliative
- Patient empowerment
- Personalised medicine
- Psychosocial
- Care
- Economics
- Global health & cancer
- Low-middle income
- Medicines
- Organisation of cancer
- Prevention
- R&D
- Regulatory
- Science domains
- Social determinants
- Technology & innovation
- Training & development
- Bioinformatics
- Biology
- Biomarkers
- Causes of cancer
- Control, survivorships & outcomes
- Detection, diagnosis & prognosis
- Devices
- Diagnostics
- Epidemiology & prevention
- Imaging
- Screening
- Antibodies & immunotherapy
- Cell therapy & stem cells
- Complications
- Cytotoxics
- Drug development
- Hormones/endocrine
- Radiotherapy
- Supportive care
- Surgery
- Targeted molecules
- Transplantation
- Vaccines & virus
- Bone
Related Videos
Updates on criteria for patient selection and surgical management in advanced ov...
Prof Pedro Ramirez - MD Anderson Cancer Center, Houston, USA
20 Jan 2021
How to improve cancer prevention and screening programmes in Romania
Dr Răzvan Curcă - Alba Iulia Emergency Hospital, Alba Iulia, Romania
19 Jan 2021
What is global oncology and what is the presence of global oncology in Europe
Prof Cristina Stefan - Institute of Oncology 'Prof Dr Alexandru Trestioreanu', B...
12 Oct 2020
PARP inhibitors and their evolving role for the treatment of prostate cancer
Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi
24 Sep 2020
The European Cancer Prevention Organization
Prof. Jaak Janssens - Hasselt, Belgium
22 Jul 2020
Who does the work in cancer control?
Dr Nazik Hammad - Queen's University, Kingston, Canada
17 Jul 2020
IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial c...
Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
30 Jun 2020
COVID-19: Management of non-small cell lung cancer patients during the coronavir...
Dr Heather Wakelee - Stanford University, Stanford, USA
12 May 2020
Where have we got to with cancer treatment?
Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrech...
27 Jan 2020
